MEDICAL MARIJUANA, INC. News
More:  CANNABIS NEWS      SHOP     CONTACT
  • About Us
    • Company
    • We are a company of firsts
    • Marijuana Industry Overview
  • Shop
    • CBD Products
    • Mood
    • Sleep
    • Skincare
  • News
    • Press Releases
    • Media Coverage
  • CBD Oil 101
    • CBD il: The Basics
    • Shop CBD Oil
    • CBD OIL FAQ´S
    • Is CBD Psychoactive?
    • CBD Serving: What is the Proper Serving Size?
    • CBD Vs THC – What Is The Difference?
    • VAPING 101
    • CBD Oil Recipes
  • Cannabis 101
    • What’s the Difference Between Hemp vs. Marijuana?
    • Where is Medical Marijuana Legal?
    • CBD Vs THC – What Is The Difference?
    • Marijuana Side Effects
    • How Long Does THC Stay in Your System?
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
Medical Marijuana, Inc. President and CEO Discusses Worldwide Potential for CBD with International Business Times

Medical Marijuana, Inc. President and CEO Discusses Worldwide Potential for CBD with International Business Times

by adminTorusBrand | Jan 23, 2017 | Company News, HempMeds Mexico, Media Coverage

[vc_row][vc_column][vc_column_text] In an interview with the International Business Times, Dr. Stuart Titus revealed how THC-free RSHO™ helped spark cannabis reform in Mexico and what the next steps are for the worldwide cannabis industry. A comprehensive article...
Medical Marijuana, Inc. Featured in International Business Times Article Highlighting RSHO-X and the State of the Global Cannabis Industry

Medical Marijuana, Inc. Featured in International Business Times Article Highlighting RSHO-X and the State of the Global Cannabis Industry

by adminTorusBrand | Jan 23, 2017 | HempMeds Mexico, Press Releases

Dr. Stuart Titus Speaks on RSHO-X’s Benefits and Cannabis Industry Updates Around the World SAN DIEGO, Jan. 23, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC PINK:MJNA), the first-ever publicly traded cannabis company in the United States, was recently...
AXIM® Biotech Begins Clinical Trial Targeting Effective Irritable Bowel Syndrome Treatment

AXIM® Biotech Begins Clinical Trial Targeting Effective Irritable Bowel Syndrome Treatment

by adminTorusBrand | Jan 18, 2017 | Axim Biotechnologies, Company News

[vc_row][vc_column][vc_column_text] AXIM® Biotechnologies Brings Their Patented CanChew® Plus Delayed-Release CBD Chewing Gum to Clinical Trials for IBS, a $1.5B market opportunity. AXIM® Biotechnologies announced this week that the company has entered clinical trials...
Medical Marijuana, Inc. Welcomes New Vice President of Data & Technology, Dirk Syburra

Medical Marijuana, Inc. Welcomes New Vice President of Data & Technology, Dirk Syburra

by adminTorusBrand | Jan 17, 2017 | HempMeds, Kannaway, Press Releases

SAN DIEGO, Jan. 17, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC PINK:MJNA), the first-ever publicly traded cannabis company in the United States, today announced that Dirk Syburra has been promoted to Vice President of Data & Technology for the company....
Medical Marijuana, Inc. Subsidiary Kannaway® Announces Exclusive Red Carpet Event in Atlanta, Georgia

Medical Marijuana, Inc. Subsidiary Kannaway® Announces Exclusive Red Carpet Event in Atlanta, Georgia

by adminTorusBrand | Jan 13, 2017 | Kannaway, Press Releases

Portfolio Company and First Hemp Lifestyle Network to Offer Cannabidiol (CBD) Products to Give Sneak Peak on New Products, Brand and Incentives SAN DIEGO, Jan. 13, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC:MJNA) announced today that its subsidiary,...
« Older Entries
Next Entries »

Recent Posts

  • Medical Marijuana, Inc. Kannaway Division Completes Acquisition of KZ1 Network Marketing Company
  • Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point
  • Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Major Features Across Several Marquee Brazilian Press Outlets

Recent Comments

No comments to show.

Home     Company     Careers     Shop

This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

Food and Drug Administration (FDA) Disclosure

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Leaving Our Website Disclaimer: If we have a research link to a website where we sell products or have product information you are now leaving the medicalmarijuanainc.com website. Links to any informational websites are provided solely as a service to our users.

The link provides additional information that may be useful or interesting and has no aliation to the promotion, sale and distribution of Medical Marijuana Inc. products. The link does not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Please view our full Terms Of Use Agreement for more information and the terms and conditions governing your use of this site.

* Cannabidiol (CBD) is a naturally-occurring constituent of the industrial hemp plant.

Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp based products.

© 2021 Medical Marijuana, Inc. All Rights Reserved.